abstract |
The invention is concerned with novel dicarboxamide derivatives of formula (I) wherein A, B, RC, D and E are as defined in the description and in the claims, as well 5as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments. |